Fast Five Quiz: Bleeding Disorders

Emmanuel C. Besa, MD


July 11, 2019

According to guidelines from the World Federation of Hemophilia, regular standardized evaluation at least every 12 months in patients with hemophilia allows for individualized care and identification of possible problems in early stages so treatment plans can be modified. Patients should also be seen by a multidisciplinary care team after every significant bleeding episode.

Oral antibiotics are only indicated if clinically necessary in patients with hemophilia undergoing dental care or management.

Prophylactic therapy with factor concentrate prevents bleeding and joint destruction. The goal of therapy should be to preserve normal musculoskeletal function. However, this does not reverse established joint damage in patients with hemophilia. It decreases the frequency of bleeding and may improve quality of life by slowing the progression of joint disease.

Implanted venous access devices may help make injections of factor concentrate easier and may be required for prophylactic administration in younger children. However, risks regarding surgery, infection, and thrombosis must be considered.

Read more on the treatment of hemophilia.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: